Restrictive lung diseases: ARDs, fibrosis, asbestosis, sarcoidosis Flashcards

1
Q

Define ARDS

A

non-cardiogenic pulmonary oedema and diffuse lung inflammation syndrome

3 criteria:

  1. acute onset (1 week)
  2. Bilateral opacities on xray
  3. PaO2/FiO2 ratio <300 on PEEP or CPAP

Commonly 2/2 critical illness but can be caused by direct lung trauma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
1
Q

Explain the pathogenesis of ARDS

A
  1. Diffuse alveolar damage → injury to the alveolar-capillary membrane
    • made up of type I and type II alveolar pneumocytes and capillary endothelial cells
  2. The alveolar air spaces are subsequently flooded with fluid, inflammatory cells and inflammatory mediators
  3. Early exudative inflammatory phase progresses to a fibroproliferative phase
  4. Fibrous tissue and collagen deposition → irreversible and sometimes catastrophic lung fibrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

State some direct and indirect causes of ARDS

A

Sepsis with pulmonary origin is the most common cause (pneumonia)

DIRECT/PULMONARY

  • aspiration- of gastric contents . 1/3rd hospitalised PTs with aspiration develop ARDS
  • burns and smoke inhalation (inc. e-cigarettes)
  • pulmonary contusion
  • transfusion-related lung injury
  • drowning
  • cardiopulmonary bypass
  • fat embolism
  • lung transplantation- primary graft dysfunction

INDIRECT/SYSTEMIC

  • sepsis
  • severe acute pancreatitis
  • severe trauma- haemorrhagic shock or later onset of multiple organ failure
  • Multiple blood transfusions
  • DIC
  • Obstetric events: eclampsia, amniotic fluid embolus
  • Drugs/toxins: aspirin, heroin, paraquat, alcohol misuse
    • depletion of endogenous antioxidants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Summarise the epidemiology of ARDS

A

1 in 6000 annually in UK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Identify appropriate investigations for ARDS and interpret the results

A

CXR

findings are similar to cardiogenic pulmonary oedema (heart failure). These are classically:

  • A - alveolar oedema (bat wing opacities)
  • B - Kerley B lines.
  • C - cardiomegaly.
  • D - dilated upper lobe vessels.
  • E - pleural effusion.

ABG

  • PaO₂/FiO₂ (inspired oxygen) ≤300 on maximum oxygen Tx

Test for underlying infection:

  • urine culture
  • sputum culture
  • blood culture
  • amylase/lipase in acute pancreatitis
  • ESR/CRP

Check for normal cardiac function

  • BNP- normal in ARDS. Sign of cardiac failure if high
  • echocardiogram- abnormal suggests cardiogenic pulmonary oedema rather than ARDS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

State and define the 2 lung diseases caused by exposure to asbestos

A

Asbestosis

Diffuse interstitial fibrosis of the lung as a consequence of exposure to absestos fibres

Malignant mesothelioma

Aggresive mesothelial neoplasm arising from the pleura (90%)/peritoneum/pericardium/tunica vaginalis

  • Direct causative link with asbestos exposure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the presenting symptoms of ARDS?

A

Acute onset:

  • Dyspnoea
  • Tachypnoea (RR>20)
  • Fever
  • Cough- may have frothy/pink sputum in pulmonary oedema
  • Pleuritic chest pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are the presenting signs of ARDS O/E?

A
  • Hypoxemia (SaO2 low despite supplementary oxygen)
  • Tachycardia
  • Cyanosis
  • Bilateral diffuse fine inspiratory crepitations
  • Peripheral vasodilation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Identify appropriate investigations for asbestosis

A

CXR: interstitial fibrosis in the lower zones and bilateral pleural thickening

Pulmonary function test: shows restrictive changes

  • reduced FVC
  • reduced TLC

HRCT chest

Bronchial lavage- presence of asbestos bodies

Lung biopsy- rarely needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain the pathogenesis of asbestosis and asbestos-related pleural changes

A

When asbestos fibres are inhaled, they deposit at alveolar duct bifurcations and cause an alveolar macrophage alveolitis.

Recruitement and activation of macrophages release cytokines (eg TNFa and IL-1b) and oxidant species:

  • → fibrosis (starts in lower lobes)
  • → oxidative stress, DNA damage, alterations in gene expression (proto-onco + tumour supressor)
    • → malignant changes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Summarise the epidemiology of asbestos-related lung disease

A

More common in men and older adults

There is a latency period of around 20 years from time of first exposure to asbestos to development of radiographical changes in asbestosis

Asbestos exposure is documented in 80% of cases of mesothelioma

(shipyard, construction, maintenance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the presenting symptoms/signs of asbestosis

A

Progressive dyspnoea

Dry, non-productive cough (unlike COPD which is productive)

Clubbing in advance disease due to hypoxia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Recognise the signs of mesothelioma O/E

A
  • Dyspnoea
  • Quiet breath sounds- due to pleural effusion, bronchial obstruction
  • Dullness to percussion (due to pleural effusion)
  • Abdo extension in peritoneal mesothelioma
  • Constitutional symptoms:
    • fatigue
    • fever
    • sweats
    • weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Identify appropriate investigations for mesothelioma

A
  1. CXR- pleural thickening/effusion. May show pleural mass and rib destruction
  2. CT contrast chest- pleural thickening and/or discrete pleural plaques, pleural and/or pericardial effusions; enlarged hilar and/or mediastinal lymph nodes; chest wall invasion
  3. Pleural fluid: may be blood stained
  4. Video-assisted thoracoscopic surgery (VATS)- diagnostic, obtain pleural biopsy for histological analysis
  5. Immunohistochemistry- specific markers eg keratins 5/6
  6. Pulmonary function tests- suitability for surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Define idiopathic pulmonary fibrosis

A

Rare, chronic, inflammatory lung disease that manifests over several years and is characterised by the formation of scar tissue within the lungs and progressive dyspnoea.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Explain the pathogenesis of idiopathic pulmonary fibrosis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Explain the pathogenesis of idiopathic pulmonary fibrosis

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Define idiopathic pulmonary fibrosis

A

Rare, chronic, inflammatory lung disease that manifests over several years and is characterised by the formation of scar tissue within the lungs and progressive dyspnoea.

22
Q

Explain the pathophysiology of iodipathic pulmonary fibrosis

A

Occurs in genetically predisposed individuals

  1. Environmental insult triggers pro-inflammatory, pro-fibrotic response
    • Pneumocytes secrete cytokines and growth factors -TGFb1
  2. → influx of macrophages, fibroblasts and other pro-inflammatory cells
  3. Normal tissue repair process is dysregulated, and fibroblast activity persists
  4. Leads to progressive fibrosis as collagen continues to be synthesised and deposited in the interstitial layer
  5. Gas exchange is reduced and alveoli become less compliant/stiffer
  6. Loss of alveoli → thick-walled cysts = honeycombing.
23
Q

State some risk factors for idiopathic pulmonary fibrosis

A

Environmental factors cause injury, triggering the abnormal fibrotic repair hallmark process of IPF:

  • Cigarette smoking- oxidative injury
  • GORD- injury induced by aspiration of acid
  • Male sex
  • Family history
  • Exposure to organic/inorganic dust- metal/wood/farming
  • Viral infection- HCV, EBV, CMV, adenovirus
  • Insulin-dependent diabetes- correlated but unknown cuasal factor
24
Q

Summarise the epidemiology of idiopathic pulmonary fibrosis

A
  • RARE
  • 6/100,000
  • More common in MALES
25
Q

What are the presenting symptoms of idiopathic pulmonary fibrosis?

A
  • Progressive dyspnoea- worse on exertion, not episodic
  • Fatigue/malaise/weight loss
  • Non-productive, irritating cough
    • can be severe and non-responsive to antitussives
26
Q

What are the presenting clinical signs of idiopathic pulmonary fibrosis?

A
  • Dry (‘velcro’), basalar end-inspiratory crackles
    • WITHOUT signs of congestive HF
  • Clubbing- late/rare
  • signs of RHF in severe disease
27
Q

What investigations would you do for idiopathic pulmonary fibrosis?

A

Bloods

  • Inflammatory markers- CRP, ESR
  • Serology- ANA in 20%, RF in 20%, anti cyclic cirrulinated peptide normal
  • (exclude collagen vascular abnormalities)
  • SaO2 reduced on exercise, pCO2 rises in late disease

Imaging

  • CXR- bilateral basal opacities. Initially gound glass, then honeycombing in late disease
  • HRCT- diagnostic

Further tests

  • Pulmonary function tests
    • reduced FVC + FEV1
    • reduce TLC
    • restrictive features
  • Biopsy
    • thoracoscopy- if HRCT/clinical evaluation not diagnostic
    • patchy interstitial inflammation
    • fibroblastic foci- patchy fibrosis of varying ages
  • Brochoalveolar lavage
    • if diagnostic uncertainty
    • raised in chronic hypersensitivity pneumonitis
28
Q

Define + categorise lung cancer

A

A group of malignant epithelial tumours arising from cells lining the lower respiratory tract.

Lung cancer is divided into two categories:

  • Non-small cell lung cancer (NSCLC) and Small cell lung cancer (SCLC)
  • NSCLC accounts for more than 80% of all lung cancers- three main types:
    • adenocarcinoma
    • squamous cell carcinoma
    • large cell carcinoma
29
Q

What are the risk factors for lung cancer?

A
  • cigarette smoking
  • environmental tobacco exposure- 2nd hand smoke
  • COPD
  • family history- 1st degreee relative doubles risk
  • radon gas exposure- occupational (mining) and residential- 10% lung cancer cases
  • older age- <10% cases before 50
  • asbestos exposure
30
Q

Summarise the epidemiology of lung cancer

A
  • Most common non-cutaneous cancer worldwide - 18% total
  • Increasing incidence- 0.5% pa- should start to decrease as tobacco use starts to decline
  • 3 x more common in MALES
  • Smoking accounts for 60-70% lung cancer
31
Q

What are the presenting symptoms of lung cancer?

A

KEY SYMPTOMS

  • Cough
    • new/persistent cough in a smoker = HIGH SUSPICION
  • Dyspnoea
    • due to: pleural effusion, airway obstruction, underlying COPD, post-obstructive pneumonia
  • Haemoptysis
  • Chest pain
    • lung itself has no pain fibres- due to invasion of tumour into pleura/chest wall
  • Pancoast tumours:
    • Horner’s syndrome- due to sympathetic plexus dysfunction
    • shoulder pain- due to invasion of brachial plexus
    • weakness/atrophy/parasthesia of C8-T1
  • Weight loss/malaise/fatigue

Due to seondary effects of cancer:

  • Hoarseness
    • recurrent larygeal nerve paralysis
  • Confusion/personality changes/headache/seizures/N+V
    • 25% lung cancer patients develop brain mets
  • Bone pain/fracture
    • mets commonly affect axial skeleton and long bones
  • Dysphagia
    • compression of tumour/enlarged mediastinal lymph nodes on oesophagus
32
Q

What are the signs of lung cancer on physical examination

A

May be no signs

  • Fixed monophonic wheeze - suggesting fixed focal obstruction
  • Signs of lobar collapse / pleural effusion
    • tracheal deviation
    • crackles
    • absent breath sounds
  • signs of mets:
    • cervical/supraclavicular lymphadenopathy
    • bone tenderness
    • proximal myopathy
    • distal neuropathy
  • Clubbing- NSCLC
33
Q

What imaging investigations would be appropriate for suspected lung cancer?

A

CXR

may detect:

  • single or multiple pulmonary nodule(s)
  • mass
  • pleural effusion
  • pneumothorax/lobar collapse
  • mediastinal or hilar fullness

Contrast-enhanced CT of the lower neck, chest, and upper abdomen -

  • shows size, location and extent of primary tumour
  • evaluates for hilar and/or mediastinal lymphadenopathy
  • shows distant metastases
  • staging

For metastases:

  • MRI/CT brain
  • PET-CT
  • Bone scan
34
Q

What non-imaging investigations would you do for lung cancer?

A

Diagnostic:

  • Bronchoscopy with brushings or biopsy – if lesion is accessable
  • CT/US-guided percutaneous biopsy- for suspicious peripheral pulmonary lesions not accessible with bronchoscopy.
  • Sputum and pleural fluid cytology
  • Lymph node biopsy

Bloods

  • FBC- normal/anaemia
  • U&Es- may have hyponatraemia
  • Calcium (hypercalcaemia is a common feature)
  • ALP (raised with bone metastases)
  • LFTs- raised in liver mets
35
Q

What is the name for an apical lung cancer? Explain the specific signs and their pathophysiology

A

Pancoast tumours

These tumours are located in the superior sulcus of the lung

Invade through the structures of the thoracic inlet:

  • Parietal pleura
    • Shoulder pain
  • Lower branches of the brachial plexus
    • parasthesia, wasting of intrinsic muscles of hand (ulner nerve damage)
  • Ribs 1+2/periosteum and cervical spine bodies
    • severe pain
  • Subclavian vein/artery → SVC syndrome
    • decreased venous return from upper extremities, face + thorax to RA
    • leads to oedema, cyanosis, vessel distension
  • Upper sympathetic ganglion
    • Horners Syndrome
  • Recurrent laryngeal nerve
    • Hoarseness
36
Q

Compare SCLC/NSCLC:

  • Location
  • Growth rate
  • Associations
  • Prognosis
A

SMALL CELL (20%)

  • central tumours
  • Fast-growing, metastasise
  • associated with SIADH (ectopic scretion of ADH by tumour)- causing hyponatraemia
  • very poor prognosis- 5yr survival = 1-24%

NON-SMALL CELL (80%)

  • peripheral tumours
  • Slower growing
  • SCC associated with PTH release → hypercalcaemia
  • adenocarcinoma associated with non-smokers
  • Prognosis slightly better but depends on stage
    • can be resected
    • large cell = poor
37
Q

List some differentials for a lung nodule on CXR

A
  • Malignancy – primary or secondary
  • Abscess
  • Granuloma
  • Carcinoid tumour
  • Pulmonary hamartoma (rare, benign)
  • AV malformation
  • Cyst
  • Foreign body
  • Skin tumour
38
Q

Define pneumoconiosis

A

The pneumoconiosis are a group of interstitial lung diseases caused by the inhalation of mineral or metal dusts

mostly occupational.

*

39
Q

What are the 3 major groups of pneumoconiosis?

A
  1. Silicosis
  2. Coal worker’s pneumoconiosis
  3. Asbestosis

First 2 are caused by macrophage ingestion of dusts- they then die and release their enzymes and cause fibrosis

40
Q

Explain the pathophysiology of pneumoconiosis

A

Smaller silica/coal/dust particles of =<5 microns gain access to the alveoli, are ingested by macrophages, and cause cytolysis of the macrophage.

Macrophages generate fibrogenic proteins and GF → stimulate collagen elaboration → fibrosis

41
Q

What does peumonconiosis often co-exist with?

A

Chronic bronchitis

42
Q

What are the risk factors for pneumoconiosis?

A
  • Occupational exposure (coal mining, quarrying, iron and steel foundries, stone cutting, sandblasting, insulation industry, plumbers, ship builders)
  • Risk is dependent on extent of exposure and the size/shape of particles
  • Individual susceptibility is also important
  • Co-factors such as smoking and TB also contribute
43
Q

Summarise the epidemiology of pneumoconiosis

A
  • Incidence is increasing in developing countries
  • Disability and mortality from asbestosis will continue to increase for the next 20-30 yrs
44
Q

Recognise the presenting symptoms of pneumoconiosis

A

May be asymptomatic - picked up on routine CXR

  • Insidious onset SOB- starts on exercise
  • Dry cough
  • Black sputum (melanoptysis) - produced occasionally in coalworker’s pneumoconiosis
  • Pleuritic chest pain (due to acute asbestos pleurisy) - in patients exposed to asbestos
45
Q

What are the signs of pneumoconiosis on examination?

A
  • crackles on chest auscultation
  • chest tightness and/or wheezing
  • prolonged expiration and wheezing on chest auscultation
  • areas of dullness on chest percussion- progressive fibrosis
  • cyanosis
  • barrel chest
  • haemoptysis, fever, or night sweats
  • clubbing of fingers and toes
  • weight loss
  • signs of rheumatoid arthritis or scleroderma
  • signs of renal failure (e.g., weight gain, oedema, hypertension)
46
Q

What investigations would you do for pneumoconiosis?

A
  • Simple: micronodular mottling
  • Complicated:
    • Nodular opacities in upper lobes
    • Micronodular shadowing
    • Eggshell calcification of hilar lymph nodes (characteristic of silicosis)
    • Bilateral lower zone reticulonodular shadowing and pleural plaques (in asbestosis)
  • CT Scan - fibrotic changes can be visualised early
  • Bronchoscopy - allows visualisation and bronchoalveolar lavage
  • Lung Function Tests - restrictive pattern
47
Q
A